Navigation Links
Smoking Increases The Risk Of Cervical Cancer In Women

A new study published in the issue of International Journal of Cancer has stated that cigarette smoking may increase the risk of cervical cancer in women//.

According to foodconsumer.org, the study, by Researchers with the International Collaboration of Epidemiological Studies of Cervical Cancer, found that current smokers were 60 percent more likely to have cervical cancer than those who never smoked.

In addition, researchers found that the risk of cervical cancer increased with the number of cigarettes smoked per day. Those started smoking at a younger age had a higher risk.

However, researchers could not find any association between smoking duration and risk of cervical cancer. The cervical cancer risk is only associated with the age at which people started smoking.

Researchers do not know the reason why there is no association between cervical cancer risk and smoking duration.

The current study per se suggests a possibility of such an association, but it cannot establish a cause-and-effect association between smoking and cervical cancer risk.


'"/>




Page: 1

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Smoking a greater risk than HIV? Yes say health experts!!!!
4. Kick Smoking with Nicotine Drink
5. Smoking spreads Cancer
6. Prescription Drug - Helps People Stop Smoking
7. Quit Smoking
8. Smoking can depreciate intellegence
9. Smoking Delays Pregnancy
10. Smoking Linked To Low Infant Birth Weight
11. GlaxoSmithKline To Cultivate Non-Smoking Environment
Post Your Comments:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...n revive its human organ donation programme in a b...elopments.// Health and Child Welfare Deputy Min... on resuscitating the programme. Because of its in...raft strong legislative laws to guard it from abus...
...US claim to have identified an alternative diet-ba...crease the growth of brain tumours. // The diet id...eyfried and other researchers is KetoCal, a commer...ydrate diet designed to treat epilepsy in children...
...ent is at loggerheads with the pharmaceutical indu...s for generic medicines. // While Thailand argues ...able to its citizens, drug companies maintain that... law and discourages foreign investment. "We were...
...on therapy may aggravate heart disease in patients...ers at Dana-Farber Cancer Institute. // ADT is one.... The study results were based on data from CaPSU...men with prostate cancer. Although the findings ne...
Other Medicine News:Health News:Diet-based Method to Treat Brain Cancer 2Health News:Drug Companies Hit Out at Thai Generic Drug Scheme 2Health News:Benefits of ADT Against Risk of Heart Ailments 2
(Date:10/7/2008)...Results of FLEXX Trial Presented at the Osteoarthr...ongress, PARSIPPANY, N.J., Oct. 7 /-...esults from the FLEXX Trial of Osteoarthritis of t...ronate), a highly pure,non-avian high molecular we...A), is superior to intra-articular saline (IA-sali...
(Date:10/7/2008)...FORT COLLINS, Colo., Oct. 7 /- A stud...ning embryonic stem cell self-renewal,reported th...m (recombinant,human serum albumin) was an effecti...culture., The article entitled, "The ground state...hat researchers used Cellastim as a recombinant,al...
(Date:10/7/2008)...Patient, Prospective Randomized Placebo-Controlled...ficant Improved Overall Survival., MOUNTAIN VIEW,...erapeutics has now evaluated the mature Phase II d...andidate PROSTVAC(TM) that had been,obtained as pa...tional,Cancer Institute (NCI) in the US., The res...
(Date:10/6/2008)...TOKYO and CHIPPENHAM, England, October 7 /PRNewswi... TSE Mothers Index: 4565) and Vectura,Group plc ("... II studies,evaluating the efficacy, safety and to...ess of the European Respiratory Society (ERS) in B...copyrronium bromide), a novel,inhaled long-acting ...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Jazz Pharmaceuticals Announces 2426 0 Million Registered Direct Offering 6576 1Jazz Pharmaceuticals Announces 2426 0 Million Registered Direct Offering 6576 2Jazz Pharmaceuticals Announces 2426 0 Million Registered Direct Offering 6576 3Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 1Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 2Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 3Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery 2645 4BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 1BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 2BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 3BioWa and Medarex Announce License of BioWas COMPLEGENT 28TM 29 Technology 6573 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 1Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2642 5
...7 /PRNewswire-FirstCall/ --,Pharmacyclics, Inc. an... novel histone deacetylase (HDAC) inhibitor and,Br...esentations,will take place at the American Associ...ng being held April 14-18, 2007, at the Los,Angele...e presentations are as follows:, Sunday, Apri...
...t EASL Conference in Barcelona,Spain, VANCOUVER a...Call/ - MIGENIX Inc. , a clinical-stage developer,... top-line results,confirming the previously announ... evidence of clinical benefit, safety and,tolerabi...osidase,inhibitor, celgosivir (MX-3253), in combin...
Other Medicine Technology:Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 2New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 3New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 4New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 5New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 6New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 7New Clinical Study Results Indicate Higher Early Virologic Response,with Celgosivir Combination Therapy in HCV Non-Responders 8
Angled 60 degree blades 5.5 mm.
Accurately tests for Nystagmus when rotated at 8-10 rpm. Drums are 10" high by 8" diameter. Light weight drum of professional quality with ball bearings for effortless spin mechanism. For use 24 to 3
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens
This Illuminated Stand Magnifier offers versatility across a number of different applications. Both the lens and the light are adjustable. Simply tilt the lens and small hand held objects can be work
Medicine Products: